Phibro Animal Health (PAHC) Competitors $39.53 -0.09 (-0.23%) Closing price 09/15/2025 04:00 PM EasternExtended Trading$40.04 +0.51 (+1.29%) As of 09/15/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PAHC vs. CYTK, AXSM, NUVL, TGTX, MRUS, CRSP, PTCT, KRYS, PCVX, and ACADShould you be buying Phibro Animal Health stock or one of its competitors? The main competitors of Phibro Animal Health include Cytokinetics (CYTK), Axsome Therapeutics (AXSM), Nuvalent (NUVL), TG Therapeutics (TGTX), Merus (MRUS), CRISPR Therapeutics (CRSP), PTC Therapeutics (PTCT), Krystal Biotech (KRYS), Vaxcyte (PCVX), and ACADIA Pharmaceuticals (ACAD). These companies are all part of the "pharmaceutical products" industry. Phibro Animal Health vs. Its Competitors Cytokinetics Axsome Therapeutics Nuvalent TG Therapeutics Merus CRISPR Therapeutics PTC Therapeutics Krystal Biotech Vaxcyte ACADIA Pharmaceuticals Phibro Animal Health (NASDAQ:PAHC) and Cytokinetics (NASDAQ:CYTK) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, profitability, earnings, analyst recommendations, media sentiment, institutional ownership, dividends and valuation. Do analysts recommend PAHC or CYTK? Phibro Animal Health currently has a consensus price target of $28.40, suggesting a potential downside of 28.16%. Cytokinetics has a consensus price target of $75.38, suggesting a potential upside of 52.48%. Given Cytokinetics' stronger consensus rating and higher possible upside, analysts clearly believe Cytokinetics is more favorable than Phibro Animal Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Phibro Animal Health 2 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.86Cytokinetics 0 Sell rating(s) 3 Hold rating(s) 11 Buy rating(s) 1 Strong Buy rating(s) 2.87 Does the media favor PAHC or CYTK? In the previous week, Phibro Animal Health had 12 more articles in the media than Cytokinetics. MarketBeat recorded 26 mentions for Phibro Animal Health and 14 mentions for Cytokinetics. Cytokinetics' average media sentiment score of 1.28 beat Phibro Animal Health's score of 0.88 indicating that Cytokinetics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Phibro Animal Health 7 Very Positive mention(s) 4 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cytokinetics 9 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, PAHC or CYTK? Phibro Animal Health has a beta of 0.88, meaning that its share price is 12% less volatile than the S&P 500. Comparatively, Cytokinetics has a beta of 0.62, meaning that its share price is 38% less volatile than the S&P 500. Is PAHC or CYTK more profitable? Phibro Animal Health has a net margin of 3.73% compared to Cytokinetics' net margin of -707.17%. Phibro Animal Health's return on equity of 32.14% beat Cytokinetics' return on equity.Company Net Margins Return on Equity Return on Assets Phibro Animal Health3.73% 32.14% 6.89% Cytokinetics -707.17%N/A -45.52% Which has preferable earnings & valuation, PAHC or CYTK? Phibro Animal Health has higher revenue and earnings than Cytokinetics. Cytokinetics is trading at a lower price-to-earnings ratio than Phibro Animal Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPhibro Animal Health$1.30B1.24$48.26M$1.1833.50Cytokinetics$18.47M320.30-$589.53M-$5.10-9.69 Do institutionals & insiders hold more shares of PAHC or CYTK? 99.3% of Phibro Animal Health shares are owned by institutional investors. 50.1% of Phibro Animal Health shares are owned by company insiders. Comparatively, 3.4% of Cytokinetics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. SummaryPhibro Animal Health beats Cytokinetics on 11 of the 17 factors compared between the two stocks. Get Phibro Animal Health News Delivered to You Automatically Sign up to receive the latest news and ratings for PAHC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PAHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PAHC vs. The Competition Export to ExcelMetricPhibro Animal HealthMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.61B$10.84B$5.79B$10.18BDividend Yield1.21%1.86%5.73%4.61%P/E Ratio33.5020.5674.8626.39Price / Sales1.2430.23543.67125.97Price / Cash12.1225.0025.8129.91Price / Book5.613.4313.256.28Net Income$48.26M$210.63M$3.29B$270.38M7 Day Performance-4.12%-1.46%0.07%1.89%1 Month Performance28.89%1.65%4.60%6.01%1 Year Performance83.60%-11.43%72.95%25.26% Phibro Animal Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PAHCPhibro Animal Health4.4441 of 5 stars$39.53-0.2%$28.40-28.2%+79.8%$1.61B$1.30B33.502,475Analyst RevisionCYTKCytokinetics4.3808 of 5 stars$52.09-1.7%$75.38+44.7%-11.5%$6.34B$18.47M-10.21250Positive NewsInsider TradeAXSMAxsome Therapeutics4.9079 of 5 stars$129.29+3.3%$177.86+37.6%+24.7%$6.25B$385.69M-25.50380Positive NewsNUVLNuvalent3.1508 of 5 stars$79.83-1.3%$120.91+51.5%-9.2%$5.83BN/A-16.2940Positive NewsTGTXTG Therapeutics4.3007 of 5 stars$32.38+0.5%$46.25+42.8%+33.8%$5.11B$329M87.51290Positive NewsInsider TradeMRUSMerus2.7953 of 5 stars$67.19-0.4%$88.75+32.1%+35.8%$5.10B$36.13M-12.2237Positive NewsCRSPCRISPR Therapeutics3.2359 of 5 stars$54.10-1.4%$71.60+32.3%+18.2%$4.99B$37.31M-9.96460PTCTPTC Therapeutics3.8027 of 5 stars$56.95-0.5%$69.00+21.2%+73.5%$4.55B$806.78M8.171,410Insider TradeKRYSKrystal Biotech4.9585 of 5 stars$145.20-3.4%$210.38+44.9%-22.8%$4.35B$290.52M29.51210Positive NewsAnalyst ForecastPCVXVaxcyte2.347 of 5 stars$32.41-1.8%$130.00+301.1%-73.3%$4.29BN/A-7.89160Positive NewsAnalyst ForecastACADACADIA Pharmaceuticals4.2107 of 5 stars$25.39+0.5%$28.88+13.7%+51.2%$4.26B$957.80M19.09510 Related Companies and Tools Related Companies CYTK Competitors AXSM Competitors NUVL Competitors TGTX Competitors MRUS Competitors CRSP Competitors PTCT Competitors KRYS Competitors PCVX Competitors ACAD Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PAHC) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredDalio’s $319 Million Gold BetA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThe End of Elon Musk…?Jeff has identified five of the past seven number-one performing tech stocks — before they took off. His Tesla...Brownstone Research | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredAmerica’s most terrifying chart?MUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Phibro Animal Health Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Phibro Animal Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PAHC Stock Alerts